HARMONY BIOSCIENCES HLDGS IN's ticker is HRMY and the CUSIP is 413197104. A total of 203 filers reported holding HARMONY BIOSCIENCES HLDGS IN in Q3 2022. The put-call ratio across all filers is 0.08 and the average weighting 0.8%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $63,342 | -35.3% | 1,800 | -40.0% | 0.04% | -36.8% |
| Q1 2023 | $97,950 | -40.7% | 3,000 | 0.0% | 0.06% | -41.2% |
| Q4 2022 | $165,300 | +20.7% | 3,000 | -3.2% | 0.10% | +16.9% |
| Q3 2022 | $137,000 | -22.2% | 3,100 | -13.9% | 0.08% | -17.8% |
| Q2 2022 | $176,000 | -11.6% | 3,600 | -12.2% | 0.10% | +1.0% |
| Q1 2022 | $199,000 | +362.8% | 4,100 | +310.0% | 0.10% | +376.2% |
| Q4 2021 | $43,000 | – | 1,000 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Valor Management LLC | 11,218,033 | $496,847,000 | 95.45% |
| Vivo Capital, LLC | 3,400,261 | $150,598,000 | 16.63% |
| Nan Fung Group Holdings Ltd | 510,978 | $22,631,000 | 14.44% |
| venBio Partners LLC | 1,125,673 | $49,856,000 | 11.54% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 264,500 | $11,715,000 | 3.76% |
| ASHFORD CAPITAL MANAGEMENT INC | 490,768 | $21,736,000 | 3.32% |
| NEUMEIER POMA INVESTMENT COUNSEL LLC | 636,485 | $28,190,000 | 2.79% |
| Octagon Capital Advisors LP | 243,500 | $10,785,000 | 1.86% |
| TANG CAPITAL MANAGEMENT LLC | 310,000 | $13,730,000 | 1.68% |
| Lisanti Capital Growth, LLC | 248,070 | $10,987,000 | 1.47% |